VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Novo Nordisk A/S vs Veeva Systems Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Novo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisVeeva Systems Inc.
VEEV · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Veeva Systems Inc.'s moat claims, evidence, and risks.
View VEEV analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 82 / 100 for Veeva Systems Inc.).
- Segment focus: Novo Nordisk A/S has 3 segments (71.1% in Diabetes care); Veeva Systems Inc. has 2 segments (53% in R&D Solutions).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Strong.
- Moat breadth: Novo Nordisk A/S has 5 moat types across 3 domains; Veeva Systems Inc. has 4 across 3.
Primary market context
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Veeva Systems Inc.
R&D Solutions
Life sciences R&D, clinical, regulatory, safety, and quality cloud applications (Vault platform-based suites)
Global
Life sciences companies plus CROs and related regulated organizations
Vertical SaaS platform owner
53%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Novo Nordisk A/S strengths
Veeva Systems Inc. strengths
Segment mix
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Veeva Systems Inc. segments
Full profile >Commercial Solutions
Oligopoly
R&D Solutions
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.